A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.
Saved in:
| Title: | A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer. |
|---|---|
| Authors: | Knox, Jennifer J.1 (AUTHOR) Jennifer.knox@uhn.ca, McNamara, Mairéad G.2 (AUTHOR), Bazin, Igor S.3 (AUTHOR), Oh, Do-Youn4 (AUTHOR), Zubkov, Oleksii.5 (AUTHOR), Breder, Valeriy3 (AUTHOR), Bai, Li-Yuan6 (AUTHOR), Christie, Alan7 (AUTHOR), Goyal, Lipika8,9 (AUTHOR), Cosgrove, David P.10 (AUTHOR), Springfeld, Christoph11 (AUTHOR), Sjoquist, Katrin M.12 (AUTHOR), Park, Joon Oh13 (AUTHOR), Verdaguer, Helena1,14 (AUTHOR), Braconi, Chiara15 (AUTHOR), Ross, Paul J.16 (AUTHOR), De Gramont, Aimery17 (AUTHOR), Shroff, Rachna T.18 (AUTHOR), Zalcberg, John R.19 (AUTHOR), Palmer, Daniel H.20 (AUTHOR) |
| Source: | Journal of Hepatology. Aug2025, Vol. 83 Issue 2, p358-366. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
